Skip to main content

Table 3 Results from mixed effects models for intervention effect estimates at each follow-up and over the entire follow-up period: adjusted, bootstrapping (2000 replications), HIV negative sample (n = 336)

From: Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial

 

Entire follow-up

3-month

6-month

12-month

PrEP Awareness

Have you heard of PrEP as an antiretroviral medication that you can take to reduce your risk of getting HIV from HIV positive partners? (OR)

3.25** [1.64, 6.46] (p = 0.001)

4.66* [1.31, 16.55] (p = 0.017)

3.98** [1.41, 11.26] (p = 0.009)

2.89 [0.79, 10.59] (p = 0.108)

Willingness to use PrEP

If PrEP is available to you, how likely would you be willing to use PrEP as an HIV prevention method? (b)

0.19** [0.06, 0.32] (p = 0.004)

0.20 [-0.002, 0.403] (p = 0.053)

0.19** [0.06, 0.33] (p = 0.006)

0.18 [-0.04, 0.40] (p = 0.116)

  1. * p < 0.05, ** p < 0.01; Note: Covariate adjustments: age, high school, employed, married, STI at baseline and baseline measure of the outcomes